First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
2024 · ESMO Open · 29 citations
https://doi.org/10.1016/j.esmoop.2024.103461
N
Natalie Prinzi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
118
Papers
2.0K
Citations
26
h-index
51
i10-index
Natalie Prinzi is an academic researcher from European Neuroendocrine Tumor Society. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Lung Cancer Research Studies & Neuroblastoma Research and Treatments. The author has an h-index of 26, co-authored 101 publications.
ORCID: 0000-0002-6261-7239Papers by this author
worksThe Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
2018 · Targeted Oncology · 19 citations
https://doi.org/10.1007/s11523-018-0567-0
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2
2023 · Journal of Hematology & Oncology · 6 citations
https://doi.org/10.1186/s13045-023-01510-9
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior
2025 · The Journal of Pathology Clinical Research · 1 citations
https://doi.org/10.1002/2056-4538.70020
Supplementary Material for: Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.10260527
Supplementary Material for: Prognostic Factors Across Poorly Differentiated Neuroendocrine Neoplasms: a Pooled Analysis
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21610326
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat